Dr. Ram Mudiyam was nterviewed by Becker's Spine Review and asked to
weigh-in on where he thought Spinal Fusion Surgery is headed in the next
The next 5 years in the spinal fusion arena
Here is an excerpt from the article:
"Although autogenous bone graft (iliac crest, local bone) remains
the "gold standard," limited supply, donor site morbidity, variable
bone quality and host factors have led to an explosion in research and
development of alternatives to autogenous bone. This is especially relevant
in long segment spinal fusions (spinal deformity) and revision cases.
These have ranged from synthetic graft extenders (ceramic, bioglass, tricalcium
phosphate), a variety of donor bone products (cortical, cancellous, structural
allografts, demineralized bone matrix, stem cell based technologies) to
bone morphogenetic protein."
To read the entire article